ASCO GUIDELINES Bundle

HR-Positive, HER2-Negative Metastatic Breast Cancer Endocrine Treatment and Targeted Therapy

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1475466

Contents of this Issue

Navigation

Page 0 of 7

GuidelineCentral.com HR-Positive, HER2- Negative Metastatic Breast Cancer Endocrine Treatment and Targeted Therapy Adapted from: Burstein HJ, et al. J Clin Oncol. 2021 July 29 doi: 10.1200/JCO.21.01392. Introduction Treatment

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - HR-Positive, HER2-Negative Metastatic Breast Cancer Endocrine Treatment and Targeted Therapy